Innovative Approach to Reduce Lung Cancer Stigma
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/24/2018 |
| Start Date: | October 27, 2018 |
| End Date: | June 1, 2019 |
| Contact: | Amy Selegue, BA, BSN, RN |
| Email: | aselegue@email.arizona.edu |
| Phone: | 520-626-0301 |
An Innovative Approach to Reduce Lung Cancer Stigma
This is a feasibility study examining the feasibility and acceptability of a novel
psychotherapy intervention on lung cancer patients who are experiencing stigma.
psychotherapy intervention on lung cancer patients who are experiencing stigma.
Experiences of stigma (perception and internalization of negative appraisal and devaluation
from others) are pervasive for lung cancer patients. Previous work has shown associations
between lung cancer stigma and detriments in clinically relevant outcomes such as depression,
lower quality of life, and reduced engagement in cancer care.
The investigators previously developed Acceptance and Commitment Therapy for Lung Cancer
Stigma (ACT-LCS) as a patient-focused intervention to reduce the self-blame, guilt and
inhibited disclosure associated with lung cancer stigma. ACT-LCS is based in Acceptance and
Commitment Therapy (ACT), a cognitive-behavioral treatment that promotes psychological
flexibility through acceptance and valued direction.
This is a feasibility study examining the feasibility and acceptability of ACT-LCS.
from others) are pervasive for lung cancer patients. Previous work has shown associations
between lung cancer stigma and detriments in clinically relevant outcomes such as depression,
lower quality of life, and reduced engagement in cancer care.
The investigators previously developed Acceptance and Commitment Therapy for Lung Cancer
Stigma (ACT-LCS) as a patient-focused intervention to reduce the self-blame, guilt and
inhibited disclosure associated with lung cancer stigma. ACT-LCS is based in Acceptance and
Commitment Therapy (ACT), a cognitive-behavioral treatment that promotes psychological
flexibility through acceptance and valued direction.
This is a feasibility study examining the feasibility and acceptability of ACT-LCS.
Inclusion Criteria:
- Proficiency in English
- Diagnosed with or treated for Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung
Cancer (SCLC) within the prior 12 months.
- Scores of 37.5 on the Lung Cancer Stigma Inventory (LCSI) screening measure
Exclusion Criteria:
- Not proficient in English
We found this trial at
1
site
Click here to add this to my saved trials
